307.51USD-0.09%Mkt Cap: 9.00B USDP/E: 40.91Last update: 2026-06-01
Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States. The company c…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap9.00B USD
Enterprise Value8.30B USD
Revenue (TTM)417.30M USD
Gross Profit366.08M USD
Net Income (TTM)204.83M USD
Revenue/Share14.36 USD
Last Price307.51 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees295
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS5011471027
Valuation
P/E (Trailing)40.91
P/E (Forward)30.66
PEG—
EV/EBITDA45.97
EV/Revenue19.88
P/S21.83
P/B7.13
EPS (TTM)7.48
EPS (Forward)10.08
52W Range
123.3294% of range319.48
52W High319.48 USD
52W Low123.32 USD
Profitability
Gross Margin94.08%
Oper. Margin46.14%
EBITDA Margin43.25%
Profit Margin52.64%
ROE16.80%
ROA15.36%
Growth
Revenue Growth31.90%
Earnings Growth52.50%
Cash Flow & Leverage
Operating CF200.87M USD
CapEx (TTM)11.95M USD
FCF Margin32.95%
FCF Yield1.53%
Net Debt-814.29M USD
Net Debt/EBITDA-4.51
Balance Sheet
Debt/Equity0.01
Current Ratio9.46
Quick Ratio8.82
Book Value/Sh43.37 USD
Cash/Share27.93 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.2 (Strong Buy)
Target (Mean)322.78 USD
Target Range241.00 USD – 399.00 USD
# Analysts9
Ownership
Shares Out.29.48M
Float23.37M
Insiders11.14%
Institutions99.43%
Short Interest
Short Ratio10.2d
Short % Float17.73%
Short % Out.10.80%
Shares Short3.18M
Short (prev mo.)2.91M
Technical
SMA 50276.27 (+11.3%)
SMA 200231.70 (+32.7%)
Beta0.49
S&P 52W Chg27.94%
Avg Vol (30d)263.79K
Avg Vol (10d)224.12K
Technical Indicators
RSI (14)60.5
MACD8.3385
MACD Signal8.8884
MACD Hist.-0.5499
BB Upper324.64 USD
BB Middle300.30 USD
BB Lower275.96 USD
BB Width16.21%
ATR (14)10.82 USD
Vol Ratio (20d)0.38x